| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.4088/JCP.08M04310 |
| P698 | PubMed publication ID | 19192472 |
| P2093 | author name string | Stephen R Marder | |
| Robert D McQuade | |||
| Ira D Glick | |||
| Philip G Janicak | |||
| Sheila Assunção-Talbott | |||
| James M Eudicone | |||
| Ronald N Marcus | |||
| David T Crandall | |||
| P433 | issue | 1 | |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 25-35 | |
| P577 | publication date | 2008-12-02 | |
| P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
| P1476 | title | The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies | |
| P478 | volume | 70 |
| Q42290826 | Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores |
| Q34121832 | Aripiprazole for late-life schizophrenia |
| Q43752043 | Changes in cognitive function associated with syndrome changes on two five-factor models of the Positive and Negative Syndrome Scale |
| Q46365588 | Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review. |
| Q48679684 | Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia |
| Q42236063 | Prominent clinical dimension, duration of illness and treatment response in schizophrenia: a naturalistic study |
| Q38473914 | Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment |
| Q64330025 | TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel |
| Q37665567 | Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis |
| Q39214475 | Utility of Two PANSS 5-Factor Models for Assessing Psychosocial Outcomes in Clinical Programs for Persons with Schizophrenia |
| Q39625587 | Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations |
Search more.